Innovent Presents Clinical Data of Two Ophthalmic Bispecific Antibodies IBI302 (anti-VEGF/complement) and IBI324 (anti-VEGF-A/Ang-2) at American Academy of Ophthalmology (AAO) Annual Meeting 2023 ...Middle East

ROCKVILLE, Md. and SUZHOU, China, Nov. 5, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune,...

Hence then, the article about innovent presents clinical data of two ophthalmic bispecific antibodies ibi302 anti vegf complement and ibi324 anti vegf a ang 2 at american academy of ophthalmology aao annual meeting 2023 was published today ( Monday 06/11/2023 - 03:01 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Presents Clinical Data of Two Ophthalmic Bispecific Antibodies IBI302 (anti-VEGF/complement) and IBI324 (anti-VEGF-A/Ang-2) at American Academy of Ophthalmology (AAO) Annual Meeting 2023 )

Also on site :

• Country Icon Carrie Underwood’s Latest Career Announcement May Leave Fans Disappointed
• Leonardo DiCaprio Reacts to Co-Star's Oscar Nomination Snub
• 9 Longest-Lasting Nail Polishes, Tested by Top Manicurists